vs
Enact Holdings, Inc.(ACT)与IDEAYA Biosciences, Inc.(IDYA)财务数据对比。点击上方公司名可切换其他公司
Enact Holdings, Inc.的季度营收约是IDEAYA Biosciences, Inc.的1.5倍($312.7M vs $207.8M)
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商,为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案,帮助首付较低的购房者获得可负担的住房贷款,助力更多美国普通消费者实现安居需求。
IDEAYA Biosciences是一家临床阶段生物技术企业,专注于肿瘤学领域,研发针对基因定义癌症的靶向疗法及合成致死治疗方案,推进多肿瘤类型的候选药物管线开发,与行业伙伴合作提升全球创新癌症治疗方案的可及性。
ACT vs IDYA — 直观对比
营收规模更大
ACT
是对方的1.5倍
$207.8M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $312.7M | $207.8M |
| 净利润 | — | $119.2M |
| 毛利率 | — | — |
| 营业利润率 | 71.3% | 52.2% |
| 净利率 | — | 57.4% |
| 营收同比 | 3.6% | — |
| 净利润同比 | — | 330.1% |
| 每股收益(稀释后) | $1.23 | $1.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACT
IDYA
| Q4 25 | $312.7M | — | ||
| Q3 25 | $311.5M | $207.8M | ||
| Q2 25 | $304.9M | — | ||
| Q1 25 | $306.8M | — | ||
| Q4 24 | $301.8M | — | ||
| Q3 24 | $309.6M | $0 | ||
| Q2 24 | $298.8M | $0 | ||
| Q1 24 | $291.6M | $0 |
净利润
ACT
IDYA
| Q4 25 | — | — | ||
| Q3 25 | — | $119.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-51.8M | ||
| Q2 24 | — | $-52.8M | ||
| Q1 24 | — | $-39.6M |
营业利润率
ACT
IDYA
| Q4 25 | 71.3% | — | ||
| Q3 25 | 67.4% | 52.2% | ||
| Q2 25 | 70.4% | — | ||
| Q1 25 | 68.9% | — | ||
| Q4 24 | 68.9% | — | ||
| Q3 24 | 74.1% | — | ||
| Q2 24 | 78.6% | — | ||
| Q1 24 | 70.6% | — |
净利率
ACT
IDYA
| Q4 25 | — | — | ||
| Q3 25 | — | 57.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
每股收益(稀释后)
ACT
IDYA
| Q4 25 | $1.23 | — | ||
| Q3 25 | $1.10 | $1.33 | ||
| Q2 25 | $1.11 | — | ||
| Q1 25 | $1.08 | — | ||
| Q4 24 | $1.05 | — | ||
| Q3 24 | $1.15 | $-0.60 | ||
| Q2 24 | $1.16 | $-0.68 | ||
| Q1 24 | $1.01 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $786.9M |
| 总债务越低越好 | $744.5M | — |
| 股东权益账面价值 | $5.4B | $1.1B |
| 总资产 | $6.9B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACT
IDYA
| Q4 25 | $582.5M | — | ||
| Q3 25 | $545.6M | $786.9M | ||
| Q2 25 | $616.0M | — | ||
| Q1 25 | $639.0M | — | ||
| Q4 24 | $602.8M | — | ||
| Q3 24 | $674.9M | $920.0M | ||
| Q2 24 | $711.3M | $701.7M | ||
| Q1 24 | $624.3M | $698.8M |
总债务
ACT
IDYA
| Q4 25 | $744.5M | — | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | — | ||
| Q1 25 | $743.4M | — | ||
| Q4 24 | $743.0M | — | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — | ||
| Q1 24 | $746.1M | — |
股东权益
ACT
IDYA
| Q4 25 | $5.4B | — | ||
| Q3 25 | $5.3B | $1.1B | ||
| Q2 25 | $5.2B | — | ||
| Q1 25 | $5.1B | — | ||
| Q4 24 | $5.0B | — | ||
| Q3 24 | $5.0B | $1.2B | ||
| Q2 24 | $4.8B | $931.7M | ||
| Q1 24 | $4.7B | $935.3M |
总资产
ACT
IDYA
| Q4 25 | $6.9B | — | ||
| Q3 25 | $6.9B | $1.2B | ||
| Q2 25 | $6.8B | — | ||
| Q1 25 | $6.7B | — | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.6B | $1.2B | ||
| Q2 24 | $6.3B | $973.7M | ||
| Q1 24 | $6.3B | $961.5M |
负债/权益比
ACT
IDYA
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $724.5M | $142.2M |
| 自由现金流经营现金流 - 资本支出 | — | $142.2M |
| 自由现金流率自由现金流/营收 | — | 68.4% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.19× |
| 过去12个月自由现金流最近4个季度 | — | $13.5M |
8季度趋势,按日历期对齐
经营现金流
ACT
IDYA
| Q4 25 | $724.5M | — | ||
| Q3 25 | $192.0M | $142.2M | ||
| Q2 25 | $119.5M | — | ||
| Q1 25 | $226.7M | — | ||
| Q4 24 | $686.3M | — | ||
| Q3 24 | $188.1M | $-49.2M | ||
| Q2 24 | $144.7M | $-32.9M | ||
| Q1 24 | $187.3M | $-43.8M |
自由现金流
ACT
IDYA
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M |
自由现金流率
ACT
IDYA
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
ACT
IDYA
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
ACT
IDYA
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图